Trial intelligence / Profile preview

Rollover Study for Continued Access to Tivozanib Hydrochloride

2009-013407-66Phase 2Completed

Sponsor

AVEO Oncology

Start

Sep 2010

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1